Extracted of the spine product line business, Dahibao medical continues to receive the third type of medical device registration certificate

Home > Health

Extracted of the spine product line business, Dahibao medical continues to receive the third type of medical device registration certificate

2021-11-30 00:04:34 42 ℃

On November 29th, Dahibao Medical Technology Co., Ltd. (hereinafter referred to as "Dahibao Medical") released an announcement, the company and its wholly-owned subsidiary Boxing Ning (Xiamen) Medical Devices Co., Ltd. (hereinafter referred to as "Xiamen Boyang") The third type of "medical device registration certificate" issued by the State Drug Administration has recently obtained.

The announcement shows that the product name obtained by the registered certificate is: the cervical vertebrae nailing system, the fixed system in the cervical vertical line. The former registered person is the Dapo Medical, valid until October 13, 2026. This product consists of cervical front fixtures and screws, non-sterilized packaging and sterilization packaging, and sterilized for 5 years. The intended use is suitable for the fixed internal fixation in the cervical path.

The registered person of the cervical vertebra after the fixed system is Xiamen Boxing, the registration certificate is valid until October 13, 2026, which is expected to be used in the rear of the pillow-C7 segment.

Dabo Medical said in the announcement, obtaining the above product registration, which is conducive to the company and wholly-owned subsidiaries to further expand the spine product line business, and enhance the company's comprehensive competitiveness, which is expected to have a positive impact on the company's future operations.

According to the data, Dabo Medical was established in 2004, the registered capital is 405 million yuan, is a comprehensive medical A-share listed enterprise mainly based on orthopedics, neurosurgery, minimally invasive surgery, and is currently about 19.3 billion yuan. The main products include orthopedic trauma implanted consumables, spine implanted consumables, joint implantation consumables, sports medicine and neurosurgery implanted consumables, minimally invasive surgical consumables, oral plant implant supplies. In the first three quarters of 2021, the company achieved operating income of 1.305 billion yuan, an increase of 17.57% year-on-year; net profit attributable to shareholders of listed companies was 453 million yuan, an increase of 6.05% year-on-year.